Free Trial

Relmada Therapeutics (RLMD) Insider Trading & Ownership

Relmada Therapeutics logo
$7.49 +0.04 (+0.54%)
Closing price 05/13/2026 04:00 PM Eastern
Extended Trading
$7.58 +0.09 (+1.19%)
As of 05/13/2026 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Relmada Therapeutics (NASDAQ:RLMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
14.50%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$1.93M
Number Of
Insiders Selling
(Last 12 Months)
0
Get RLMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Relmada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RLMD Insider Buying and Selling by Quarter

Relmada Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/15/2025Buy11,665$4.12$48,059.80  
11/5/2025Buy136,000$2.20$299,200.00  
11/5/2025Buy500,000$2.20$1,100,000.00  
11/5/2025Buy90,000$2.20$198,000.00  
5/20/2025Buy60,000$0.52$31,200.00  
5/19/2025Buy90,000$0.49$44,100.00  
5/16/2025
Chuck Ence
Chuck Ence
Insider
Buy228,961$0.45$103,032.45  
5/16/2025Buy50,000$0.44$22,000.00  
5/16/2025Buy200,000$0.43$86,000.00  
(Data available from 1/1/2013 forward)

RLMD Insider Trading Activity - Frequently Asked Questions

The list of insiders at Relmada Therapeutics includes Cedric O'gorman, Charles J Casamento, Chuck Ence, Maged Shenouda, Paul Edward Kelly, and Sergio Traversa. Learn more on insiders at RLMD.

14.50% of Relmada Therapeutics stock is owned by insiders. Learn more on RLMD's insider holdings.

The following insiders have purchased RLMD shares in the last 24 months: Charles J Casamento ($33,280.00), Chuck Ence ($402,232.45), Maged Shenouda ($1,337,408.50), Paul Edward Kelly ($284,000.00), and Sergio Traversa ($304,326.02).

Insiders have purchased a total of 1,518,926 RLMD shares in the last 24 months for a total of $2,361,246.97 bought.



This page (NASDAQ:RLMD) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners